Eli Lilly and Company (BVMF:LILY34)
179.78
-3.69 (-2.01%)
At close: Dec 4, 2025
Eli Lilly and Company Market Cap
Eli Lilly and Company has a market cap or net worth of 4.91 trillion as of December 4, 2025. Its market cap has increased by 26.01% in one year.
Market Cap
4.91T
Enterprise Value
5.08T
Revenue
316.67B
Ranking
n/a
PE Ratio
50.02
Stock Price
179.78
Market Cap Chart
Since July 9, 1970, Eli Lilly and Company's market cap has increased from 3.09B to 4.91T, an increase of 158,695.08%. That is a compound annual growth rate of 14.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 4.91T | 14.15% |
| Dec 31, 2024 | 4.30T | 69.02% |
| Dec 29, 2023 | 2.54T | 38.42% |
| Dec 30, 2022 | 1.84T | 31.71% |
| Dec 31, 2021 | 1.40T | 75.52% |
| Dec 31, 2020 | 794.91B | 56.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 101.09B |
| Raia Drogasil | 41.21B |
| Hypera | 16.96B |
| Fleury | 8.28B |
| Odontoprev | 6.42B |
| Diagnósticos da América | 4.31B |
| Empreendimentos Pague Menos | 4.01B |
| Blau Farmacêutica | 2.38B |